| Charles Azubuike Anene, MD | |
|
300 W 27th St, Lumberton, NC 28358-3075 | |
| (910) 671-5000 | |
| Not Available |
| Full Name | Charles Azubuike Anene |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 39 Years |
| Location | 300 W 27th St, Lumberton, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124108303 | NPI | - | NPPES |
| 0071575000 | Other | AMERIHEALTH | |
| 012207 | Other | NJ | MEDICARE |
| 2372299 | Other | AETNA | |
| 8438706 | Other | NJ MEDICAL ASSISTANCE | |
| 0152107202 | Other | AMERICHOICE | |
| 1125019 | Other | KEYSTONE MERCY HEALTH PLA | |
| 8211867002 | Other | CIGNA | |
| 019033 | Other | HIGHMARK | |
| 0071575000 | Other | IBC | |
| 001820720001 | Medicaid | PA | |
| 330005393 | Other | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeastern Regional Medical Center | Lumberton, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Regional Physician Services | 7012058548 | 32 |
News Archive
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
For America's 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In this era of assembly-line appointments, when you're lucky to get 10 minutes of face time with a physician, the idea of doctors making house calls seems old fashioned.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
› Verified 8 days ago
| Entity Name | Cumberland County Hospital System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881946242 PECOS PAC ID: 1850204041 Enrollment ID: O20031112000693 |
News Archive
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
For America's 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In this era of assembly-line appointments, when you're lucky to get 10 minutes of face time with a physician, the idea of doctors making house calls seems old fashioned.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
› Verified 8 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
For America's 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In this era of assembly-line appointments, when you're lucky to get 10 minutes of face time with a physician, the idea of doctors making house calls seems old fashioned.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
› Verified 8 days ago
| Entity Name | Southeastern Regional Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427282045 PECOS PAC ID: 7012058548 Enrollment ID: O20100106000556 |
News Archive
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
For America's 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In this era of assembly-line appointments, when you're lucky to get 10 minutes of face time with a physician, the idea of doctors making house calls seems old fashioned.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Azubuike Anene, MD Po Box 63362, Charlotte, NC 28263-3362 Ph: (800) 782-6945 | Charles Azubuike Anene, MD 300 W 27th St, Lumberton, NC 28358-3075 Ph: (910) 671-5000 |
News Archive
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
For America's 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In this era of assembly-line appointments, when you're lucky to get 10 minutes of face time with a physician, the idea of doctors making house calls seems old fashioned.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
› Verified 8 days ago
Dominic L Storto, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 2934 N Elm St Ste E, Lumberton, NC 28358 Phone: 919-739-0022 Fax: 910-738-0079 | |
Dr. Jason Evan Davis, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2934 N Elm St Ste E, Lumberton, NC 28358 Phone: 910-739-0022 Fax: 910-739-0079 | |
Jayme Emil Mcarthur-herder, MD Surgery Medicare: Medicare Enrolled Practice Location: 2934 N Elm St Ste E, Lumberton, NC 28358 Phone: 910-739-0022 Fax: 910-738-0079 | |
Rakesh Kumar, M.B.B.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2934 N Elm St Ste E, Lumberton, NC 28358 Phone: 910-739-0022 Fax: 910-739-0079 | |
Melvin Dubose Medlock Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2934 N Elm St Ste E, Lumberton, NC 28358 Phone: 910-739-0022 Fax: 910-739-0079 | |
Dr. Donald D Glower Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 403 W 27th St, Lumberton, NC 28358 Phone: 919-684-8111 | |
Peter L Villani, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3001 North Elm Street, Lumberton, NC 28358 Phone: 910-738-8556 Fax: 910-738-2275 |